When was BioAscent founded?

BioAscent was founded in 2013 and raised its 1st funding round within a year of its incorporation.

Where is BioAscent located?

BioAscent is headquartered in Motherwell, United Kingdom. It is registered at C/O Cms Cameron Mckenna Nabarro Olswang Llp Saltire Court, 20 Castle Terrace, Edinburgh, United Kingdom, EH1 2EN.

Which legal entities is BioAscent associated with?

BioAscent is associated with BIOASCENT DISCOVERY LIMITED.

How many employees does BioAscent have?

As of Jun 30, 2026, the latest employee count at BioAscent is 74.

Is BioAscent a funded company?

BioAscent is a funded company, having raised a total of $3.7M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Nov 09, 2013.

How much is BioAscent worth?

The latest valuation of BioAscent is $***** as of Jun 20, 2018.

When was the latest funding round of BioAscent?

BioAscent's latest funding was a $***** Seed round on Jun 20, 2018, with participation from 1 investor.

Where does BioAscent rank among its competitors?

BioAscent ranks 17th amongst 377 active competitors, of which 14 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Ember LifeSciences, which secured $27M in May, 2026.

Who are the top competitors of BioAscent?

BioAscent's top competitors include McKesson, Resilience and Take Solutions. Among them, Ember LifeSciences secured the most recent funding round in May, 2026.

BioAscent - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

BioAscent is a provider of compound management solutions for drug discovery. Their service portfolio includes Compound Management, Compound Cloud, Compound Collection Sharing, and Compound Collection Disaster Recovery. The company is currently operating a former automated compound Management and Logistics facility of Merck. They offer a confidential partner-matching service which facilitates compound collection sharing (based on owner's terms) with pharma, biotech and academic institutes.

Website: www.bioascent.com/
Email ID: *****@bioascent.com
Phone Number: +44 **********
Registered Address: C/O Cms Cameron Mckenna Nabarro Olswang Llp Saltire Court, 20 Castle Terrace, Edinburgh, United Kingdom, EH1 2EN

Key Metrics

Founded Year

2013

Location

Motherwell, United Kingdom

Stage

Seed

Total Funding

$3.7M in 3 rounds

Latest Funding Round

Seed, Jun 20, 2018, $*****

Post Money Valuation

$***** as on Jun 20, 2018

Investors

Pioneer Group & 2 more

Ranked

17^th among 377 active competitors

Employee Count

74 as on Jun 30, 2026

Similar Companies

McKesson & 423 more

View BioAscent's full profile

BioAscent is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BIOASCENT DISCOVERY LIMITED CIN: SC442915 , United Kingdom, Active	Feb 14, 2013	-	41 (As on Jan 31, 2020)

BioAscent has raised a total funding of $3.7M over 3 rounds. Its first funding round was on Nov 09, 2013. Its latest funding round was a Seed round on Jun 20, 2018 for $*****. 1 investor participated in its latest round. BioAscent has 3 institutional investors.

Here is the list of recent funding rounds of BioAscent:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 20, 2018	4607781	Seed	7131461	9747588	7458504	6179690
Mar 20, 2014	7039858	Seed	6064335	2660148	6033519	6816733
Nov 09, 2013	7368757	Seed	6230144	1972456	4684591	9114252

Access funding benchmarks and valuations. Sign up today!

View details of BioAscent's funding rounds and investors

The founders of BioAscent is Sylviane Boucharens.

Here are the details of BioAscent's key team members:

Sylviane Boucharens: Co-Founder & COO of BioAscent and founder of 1 other company.
Contact Info: 1 email address
Paul Smith: Co-Founder & CEO of BioAscent.

View details of BioAscent's Founder profiles and Board Members

BioAscent's employee count trend

BioAscent has 74 employees as of Jun 26. Here is BioAscent's employee count trend over the years:

Uncover BioAscent's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BioAscent include McKesson, Resilience and Take Solutions. Here is the list of Top 10 competitors of BioAscent, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	McKesson 1833, Irving (United States), Public	Provider of products and services in the healthcare industry	-	Greyrock Investments, Petrillo Capital & 9 others	68/100
2nd	Resilience 1995, San Diego (United States), Series D	Provider of supply chain services for biopharma sector	$1.99B	Mubadala, Kennet Partners & 19 others	65/100
3rd	Take Solutions 2000, Chennai (India), Public	Provider of life sciences and supply chain management services	-	Jina Ventures	62/100
4th	CubeWorks 2013, Ann Arbor (United States), Series A	Provider of millimeter-scale wireless sensors	$15.3M	Intel Capital, Zell Lurie & 4 others	53/100
5th	ASP Isotopes 2021, Boca Raton (United States), Public	Provider of supply chain solution services	-	Las Olas Capital	53/100
6th	Ember LifeSciences 2022, Westlake Village (United States), Series A	Provider of cold chain logistics services for biopharma sector	$64.4M	Sea Court Capital, Carrier & 4 others	50/100
7th	Tobin Scientific 1960, Beverly (United States), Series C	Provider of cold chain logistics services for biopharma sector	$65M	Denali Growth, Truck 9 Partners & 1 others	48/100
8th	Wipak 2010, Helsinki (Finland), Funding Raised	Provider of packaging and logistic services	-	Europa	44/100
9th	Frigo Logistics 2001, Znin (Poland), Unfunded	Provider of logistics services for biopharma sector	-	-	44/100
10th	Credent Cold Chain Logistics 2015, Delhi (India), Unfunded	Cold chain logistics solutions for pharmaceuticals, medical and other industries.	-	-	43/100
17th	BioAscent 2013, Motherwell (United Kingdom), Seed	Compound management solutions for drug discovery	$3.7M	Pioneer Group, Maven Capital Partners & 1 others	40/100